This case highlights the diagnostic challenges of ITP in older adults and supports combining thrombopoietin receptor agonists (TPO-RAs) with targeted immunosuppressive therapy in steroid-refractory disease. This evidence concerns the gene TPO and autoimmune thrombocytopenic purpura.